Current Pharmaceutical Biotechnology

Bentham Science Publishers

Evaluation status available after sign-in

About the journal

Current Pharmaceutical Biotechnology is a journal published by Bentham Science Publishers in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Bentham Science Publishers
ISSN
1389-2010 · 1873-4316
Country
Netherlands
Access
Not open access / not declared

Index listings

  • MEDLINE · 2000-01-01
  • PUBMED · 2010-09-01
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Actual review time (measured)
83 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

3449

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

113

i10-index

1717

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
66%
ORCID iDs in current deposits
46%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
100960530
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
Show all subjects (50)
  • Cancer Mechanisms and Therapy
  • Cancer Mechanisms and Therapy
  • 14-3-3 protein interactions
  • 14-3-3 protein interactions
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Protein purification and stability
  • Protein purification and stability
  • Nanoparticles: synthesis and applications
  • Nanoparticles: synthesis and applications
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Phytochemicals and Antioxidant Activities
  • Phytochemicals and Antioxidant Activities
  • Transgenic Plants and Applications
  • Advancements in Transdermal Drug Delivery
  • Curcumin's Biomedical Applications
  • Advancements in Transdermal Drug Delivery
  • Transgenic Plants and Applications
  • Curcumin's Biomedical Applications
  • Nanoplatforms for cancer theranostics
  • Viral Infectious Diseases and Gene Expression in Insects
  • Viral Infectious Diseases and Gene Expression in Insects
  • Nanoplatforms for cancer theranostics
  • Essential Oils and Antimicrobial Activity
  • Essential Oils and Antimicrobial Activity
  • Gut microbiota and health
  • Gut microbiota and health
  • Glycosylation and Glycoproteins Research
  • Glycosylation and Glycoproteins Research
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • Bacteriophages and microbial interactions
  • Bacteriophages and microbial interactions
  • Microbial Natural Products and Biosynthesis
  • Microbial Natural Products and Biosynthesis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: